Skip to main content

May 2018, Vol 8, No 5







Immunotherapies have transformed the treatment of cancer, but patients who receive immune checkpoint inhibitors may experience a range of side effects, which are only recently becoming familiar to oncologists and patients. Read More ›




Page 1 of 2